Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
cyclophosphamide (cytoxan) (1 trial)
cytarabine (cytosar-u) (1 trial)
doxorubicin (Doxil) (1 trial)
prednisone (meticorten) (1 trial)
rituximab (rituxan) (1 trial)
urea (1 trial)
vincristine (oncovin) (1 trial)
Lymphoproliferative Disorders (Phase 2)
Trials (1 total)
Trial APIs (7 total)